Sign in

CIK 0001062822

  • Non-accelerated filer
  • Smaller reporting company

LEXICON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
LXRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760474169
Phone
+1 281-863-3000
Business address
2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
Former names
LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
Open-market buys, last 90 days
$49,999
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Exton Michael +$50K Chief Executive Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2019-02-28 Lapuerta Pablo EVP and CMO Exercise or conversion · Restricted Stock Units −8,570 17,140
2019-02-28 COATS LONNEL President and CEO Exercise or conversion +10,835 68,914
2019-02-28 COATS LONNEL President and CEO Exercise or conversion +8,390 77,304
2019-02-28 COATS LONNEL President and CEO Exercise or conversion +5,363 82,667
2019-02-28 COATS LONNEL President and CEO Exercise or conversion +23,513 106,180
2019-02-28 COATS LONNEL President and CEO Shares withheld for taxes −18,641 $5.51 $103K 87,539
2019-02-28 COATS LONNEL President and CEO Exercise or conversion · Restricted Stock Units −10,835 0
2019-02-28 COATS LONNEL President and CEO Exercise or conversion · Restricted Stock Units −8,390 8,390
2019-02-28 COATS LONNEL President and CEO Exercise or conversion · Restricted Stock Units −5,363 10,725
2019-02-28 COATS LONNEL President and CEO Exercise or conversion · Restricted Stock Units −23,513 47,027
2019-02-07 Tessmer James F VP, Finance & Accounting Grant or award · Stock Option (Right to Buy) +39,770 39,770
2019-02-07 Tessmer James F VP, Finance & Accounting Grant or award · Restricted Stock Units +26,510 26,510
2019-02-07 TYLE PRAVEEN EVP, R&D Grant or award · Stock Option (Right to Buy) +148,200 148,200
2019-02-07 TYLE PRAVEEN EVP, R&D Grant or award · Restricted Stock Units +79,800 79,800
2019-02-07 Santini Alexander A EVP and CCO Grant or award · Stock Option (Right to Buy) +127,320 127,320
2019-02-07 Santini Alexander A EVP and CCO Grant or award · Restricted Stock Units +68,560 68,560
2019-02-07 MAIN ALAN J EVP, Commercial Supply Ops Grant or award · Stock Option (Right to Buy) +124,640 124,640
2019-02-07 MAIN ALAN J EVP, Commercial Supply Ops Grant or award · Restricted Stock Units +67,120 67,120
2019-02-07 Lapuerta Pablo EVP and CMO Grant or award · Stock Option (Right to Buy) +130,710 130,710
2019-02-07 Lapuerta Pablo EVP and CMO Grant or award · Restricted Stock Units +70,390 70,390

Page 48 of 51 · 1,001 trades